Skip to main content
. 2017 Aug 5;8(40):67117–67128. doi: 10.18632/oncotarget.19962

Figure 5. Mitochondrial complex I and II proteins are associated with poor clinical outcome in gastric cancer patients.

Figure 5

A. Note that high levels of NDUFS5 and NDUFA5 predict significantly reduced time to first progression. B. Similarly, high levels of SDHB predict significantly reduced time to first progression.